Drug Shortage Report for TEVA-TERBINAFINE
Report ID | 1655 |
Drug Identification Number | 02240346 |
Brand name | TEVA-TERBINAFINE |
Common or Proper name | TERBINAFINE |
Company Name | TEVA CANADA LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | TERBINAFINE |
Strength(s) | 250MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 28 |
ATC code | D01BA |
ATC description | ANTIFUNGALS FOR SYSTEMIC USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2016-10-18 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2020-02-13 |
Company comments | Product is being evaluated |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2020-02-13 | French | Compare |
v6 | 2020-02-13 | English | Compare |
v5 | 2017-10-10 | French | Compare |
v4 | 2017-10-10 | English | Compare |
v3 | 2017-03-14 | French | Compare |
v2 | 2017-03-13 | French | Compare |
v1 | 2017-03-13 | English | Compare |
Showing 1 to 7 of 7